等待開盤 11-04 09:30:00 美东时间
+1.070
+2.36%
今日重点评级关注:Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至118美元;Canaccord Genuity:维持Aclaris Therapeutics"买入"评级,目标价从10美元升至13美元
11-02 18:53
华盛资讯10月30日讯,APi Group公布2026财年Q3业绩,公司Q3营收25.54亿美元,同比增长22.49%,归母净利润1.02亿美元,同比增长21.43%。
10-30 03:49
APi Group shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY26 sales guidance above estimates. Also, the company issued Q4 sales guidance above estimates.
10-29 20:47
华盛资讯10月29日讯,APi Group公布2026财年Q3业绩,公司Q3营收25.54亿美元,同比增长22.5%,归母净利润1.02亿美元,同比增长21.4%。
10-29 20:35
APi Gr (NYSE:APG) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.47 by 6.38 percent. This is a 21.95 percent increase over earnings of $0.41 per share from the same period last year. The company reported quarterly sales of $2.554 billion which beat the...
10-29 19:38
APi Group (NYSE:APG) raises FY2026 sales outlook from $8.875 billion-$9.025 billion to $9.200 billion-$9.250 billion vs $8.994 billion estimate.
10-29 19:31
APi Group (NYSE: APG) 公布2026财年第三季度净营收为25.54亿美元,同比增长22.5%,有机增长15.7%。GAAP稀释后每股收益从0.20美元增至0.24美元;调整后EBITDA增长24.6%至3.5亿美元,利润率扩大20个基点至13.7%。专业服务部门领跑各业务板块增长,但受项目与业务组合变动以及原材料、燃料和其他费用上涨影响,综合毛利率下滑120个基点。此外,APi还上调了2026财年全年的营收及调整后EBITDA业绩指引。
10-29 11:45
今日重点评级关注:摩根士丹利:维持TeraWulf"超配"评级,目标价从62.5美元升至65美元;摩根士丹利:维持Hut 8"超配"评级,目标价从273美元升至275美元
10-13 12:30
Citigroup analyst Andrew Kaplowitz maintains APi Group (NYSE:APG) with a Buy and raises the price target from $54 to $55.
10-13 04:20
UBS Global Research has constructed a 56-stock basket of U.S. companies with higher forward growth, stronger cash-flow profitability and improving earnings momentum, arguing that valuations for some o...
10-08 18:29